CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer

INTRODUCTION: We performed gene expression analysis to identify molecular predictors of resistance to preoperative concomitant trastuzumab and paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide (T/FEC). METHODS: Pretreatment fine-needle aspiration specimens from 45 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Esteva, Francisco J, Wang, Jing, Lin, Feng, Mejia, Jaime A, Yan, Kai, Altundag, Kadri, Valero, Vicente, Buzdar, Aman U, Hortobagyi, Gabriel N, Symmans, W Fraser, Pusztai, Lajos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246190/
https://www.ncbi.nlm.nih.gov/pubmed/18086299
http://dx.doi.org/10.1186/bcr1836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246190/
https://www.ncbi.nlm.nih.gov/pubmed/18086299
http://dx.doi.org/10.1186/bcr1836

Ejemplares similares